Cell surface markers have been used in some cancers to produce a population of cells enriched with stem cell properties, for example, CD133 in the identification of human glioma (Singh et al, 2004) and colon cancer (Ricci-Vitiani et al, 2007) stem cells. This evidence concerns the gene PROM1 and colonic neoplasm.